amiodarone has been researched along with Endocrine System Diseases in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Endocrine System Diseases: Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lakatos, P | 1 |
Thomas, Z | 1 |
Bandali, F | 1 |
McCowen, K | 1 |
Malhotra, A | 1 |
1 review available for amiodarone and Endocrine System Diseases
Article | Year |
---|---|
Drug-induced endocrine disorders in the intensive care unit.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antifungal Agents; Antimanic Agents; Critical Care; Cytochrome P | 2010 |
1 other study available for amiodarone and Endocrine System Diseases
Article | Year |
---|---|
[Editor's commentary. Advances in endocrinology].
Topics: Amiodarone; Anti-Arrhythmia Agents; Diabetic Neuropathies; Endocrine System Diseases; Female; Humans | 2013 |